QOAR: Vertebral Bone Quality and Prediction of Screw Loosening in Spine Fusion

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03650855
Collaborator
(none)
28
1
45
0.6

Study Details

Study Description

Brief Summary

Finding a way to use Vertebral CT scan will help to predict screw loosing risk in spinal fusion for degenerative spine disease. Patients who will undergo at least two spine fusion levels for degenerative spine disease will be enrolled in. Before surgery, patients will undergo a spinal QCT scan with a calibrated phantom. The calibrated bone density, at bone-implant interface, will be assessed using dual energy CT scan immediately after surgery, and six months later. The primary outcomes will be the difference between the two values of the bone implant interface. The difference between density values will be correlated to the pre-op bone density value.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Screw loosening is a real problem in degenerative spine surgery because of the morbidity of secondary surgery sometimes needed for elderly patients. Today, there is no real possibility to know before surgery if cemented screws are needed or not. The use of cemented screws has its morbidity. In fact, bone densitometry is not a good exam to predict the bone quality in degenerative spine because of the arthritis. T-score in degenerative spine can be overestimated. The goal of our study is analyze the bone-implant interface after spine fusion using dual-energy CT scan technology which can provide pictures without artifact compared to standard CT scan. This is a prospective observational monocentric study. Patients over 18 years old and have undergone at least two primary spine fusion levels will be enrolled. The exclusion criteria are the use of cemented screws, secondary surgery and neurodegenerative disease. The primary outcome will be the change in the bone-implant interface at six months post-surgery compared to the interface after surgery. The change will be assessed by calibrated dual CT scan. The interface bone density will be assessed using calibrated scans, and correlate to the true vertebral bone density measured before surgery with a QCT. We hope that this study can provide a simple and reproducible help for surgeons to choose between uncommented and cemented screws for their spine fusions surgeries.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    28 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Vertebral Bone Quality and Prediction of Screw Loosening in Spine Fusion
    Actual Study Start Date :
    Sep 25, 2018
    Anticipated Primary Completion Date :
    Jun 25, 2022
    Anticipated Study Completion Date :
    Jun 25, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Change of bone-implant interface at 6-month follow up compared to post operative interface assessed on Dual energy CT Scan [6 montths]

      Assessment of bone-implant interface (1 to 3 mm around the screw) using calibrated bone density on spinal dual energy CT scan just after surgery and at 6 months of follow up. Comparison between the two measured values.

    Secondary Outcome Measures

    1. evolution of bone density of non instrumented levels between T0 and 6 months follow up assessed with Dual Energy CT scan [6 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • More than 18 years old

    • needed a minimum 2 levels spinal fusion

    • agreed protocol

    Exclusion Criteria:
    • Cimented pedicular screws

    • secondary surgery

    • neurodegenerative disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hôpital Pitié Salpêtrière Paris France 75013

    Sponsors and Collaborators

    • Assistance Publique - Hôpitaux de Paris

    Investigators

    • Principal Investigator: Hugues HM PASCAL-MOUSSELARD, PH, Assistance Publique - Hôpitaux de Paris

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Assistance Publique - Hôpitaux de Paris
    ClinicalTrials.gov Identifier:
    NCT03650855
    Other Study ID Numbers:
    • NI17046J
    First Posted:
    Aug 29, 2018
    Last Update Posted:
    Mar 22, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Assistance Publique - Hôpitaux de Paris
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 22, 2022